- Home
- SLMT vs PMI Comparison
SLMT vs PMI Comparison
Compare SLMT & PMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | SLMT | PMI |
|---|---|---|
| Founded | 2000 | 1981 |
| Country | | |
| Employees | N/A | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 170.9M | 202.7M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | SLMT | PMI |
|---|---|---|
| Price | $1.18 | $1.47 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 943.9K | ★ 1.6M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.99 | $1.30 |
| 52 Week High | $24.05 | $13.68 |
Technical Indicators
Market Signals| Indicator | SLMT | PMI |
|---|---|---|
| Relative Strength Index (RSI) | 35.86 | 39.54 |
| Support Level | $0.99 | $1.30 |
| Resistance Level | $1.32 | $2.50 |
| Average True Range (ATR) | 0.16 | 0.26 |
| MACD | 0.04 | -0.01 |
| Stochastic Oscillator | 34.58 | 19.17 |
Price Performance
Historical ComparisonAbout SLMT Brera Holdings PLC Class B Ordinary Shares
Brera Holdings PLC focused on expanding social impact football by developing a international portfolio of emerging football clubs with increased opportunities to earn tournament prizes, gain sponsorships, and provide other professional football and related consulting services.
About PMI Picard Medical Inc.
Picard Medical Inc operates through its wholly owned subsidiary, a medical technology company focused on developing, manufacturing, and commercializing an implantable Total Artificial Heart. It is engaged in designing, manufacturing, producing, supplying, marketing, and selling medical device products, including TAH. The TAH is an implantable system designed to assume the full function of a failed human heart in patients suffering from advanced heart failure.